West Pharmaceutical Services, Inc. is rated a Hold due to exemplary dividend safety and a fortress balance sheet. Read more ...

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG ("Araris") today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) ...

Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) ranks among the most profitable biotech stocks to buy now. Following comments on ...

By Puyaan Singh April 27 (Reuters) - Ligand Pharmaceuticals will buy fellow biotechnology royalty aggregator XOMA Royalty for ...

With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British biotech’s future.

Michael Yee, UBS global head of biotech research, joins 'Squawk Box' to discuss the quarterly earnings results of Merck and Eli Lilly, opportunities in pharma stocks, and more.

Regeneron Pharmaceuticals' board has added $3 billion to the biotechnology company's stock-buyback program. Regeneron on Wednesday said the new authorization adds to the $688 million remaining under ...

Seaport will use the funds for its neuropsychiatric drug pipeline, while Hemab will focus on bleeding disorder medicines.

J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...

As of the April 24 closing, the stock carries a strongly bullish consensus sentiment. With a price target of $86.71, it ...